Selected research
Industry Research
Pet Intestinal Medicine Industry Research Report 2026
Market perspective
The global Pet Intestinal Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pet Intestinal Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pet Intestinal Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pet Intestinal Medicine include Boehringer Ingelheim, CAHIC, Ceva, Dechra Veterinary Products, Elanco, Jindun, Norbrook, Ouro Fino Saude and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pet Intestinal Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Intestinal Medicine Market by Company
Boehringer Ingelheim
CAHIC
Ceva
Dechra Veterinary Products
Elanco
Jindun
Norbrook
Ouro Fino Saude
Vetoquinol
Virbac
Wuhan chopperlvya
Merck
Zoetis
Pet Intestinal Medicine Segment by Type
Powder
Liquid
Pet Intestinal Medicine Segment by Application
Reptile
Cat
Dog
Other
Pet Intestinal Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Intestinal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Intestinal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Intestinal Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Intestinal Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Intestinal Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Liquid
Applications
- Reptile
- Cat
- Dog
- Other
Companies covered
- Boehringer Ingelheim
- CAHIC
- Ceva
- Dechra Veterinary Products
- Elanco
- Jindun
- Norbrook
- Ouro Fino Saude
- Vetoquinol
- Virbac
- Wuhan chopperlvya
- Merck
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pet Intestinal Medicine Market Size (2021-2032)
- 2.2.2 Global Pet Intestinal Medicine Sales (2021-2032)
- 2.2.3 Global Pet Intestinal Medicine Market Average Price (2021-2032)
- 2.3 Pet Intestinal Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Liquid
- 2.4 Pet Intestinal Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Reptile
- 2.4.3 Cat
- 2.4.4 Dog
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pet Intestinal Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pet Intestinal Medicine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pet Intestinal Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Pet Intestinal Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Pet Intestinal Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pet Intestinal Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pet Intestinal Medicine, Product Type & Application
- 3.8 Global Manufacturers of Pet Intestinal Medicine, Established Date
- 3.9 Global Pet Intestinal Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 CAHIC
- 4.2.1 CAHIC Company Information
- 4.2.2 CAHIC Business Overview
- 4.2.3 CAHIC Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CAHIC Pet Intestinal Medicine Product Portfolio
- 4.2.5 CAHIC Recent Developments
- 4.3 Ceva
- 4.3.1 Ceva Company Information
- 4.3.2 Ceva Business Overview
- 4.3.3 Ceva Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ceva Pet Intestinal Medicine Product Portfolio
- 4.3.5 Ceva Recent Developments
- 4.4 Dechra Veterinary Products
- 4.4.1 Dechra Veterinary Products Company Information
- 4.4.2 Dechra Veterinary Products Business Overview
- 4.4.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
- 4.4.5 Dechra Veterinary Products Recent Developments
- 4.5 Elanco
- 4.5.1 Elanco Company Information
- 4.5.2 Elanco Business Overview
- 4.5.3 Elanco Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Elanco Pet Intestinal Medicine Product Portfolio
- 4.5.5 Elanco Recent Developments
- 4.6 Jindun
- 4.6.1 Jindun Company Information
- 4.6.2 Jindun Business Overview
- 4.6.3 Jindun Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jindun Pet Intestinal Medicine Product Portfolio
- 4.6.5 Jindun Recent Developments
- 4.7 Norbrook
- 4.7.1 Norbrook Company Information
- 4.7.2 Norbrook Business Overview
- 4.7.3 Norbrook Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Norbrook Pet Intestinal Medicine Product Portfolio
- 4.7.5 Norbrook Recent Developments
- 4.8 Ouro Fino Saude
- 4.8.1 Ouro Fino Saude Company Information
- 4.8.2 Ouro Fino Saude Business Overview
- 4.8.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
- 4.8.5 Ouro Fino Saude Recent Developments
- 4.9 Vetoquinol
- 4.9.1 Vetoquinol Company Information
- 4.9.2 Vetoquinol Business Overview
- 4.9.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
- 4.9.5 Vetoquinol Recent Developments
- 4.10 Virbac
- 4.10.1 Virbac Company Information
- 4.10.2 Virbac Business Overview
- 4.10.3 Virbac Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Virbac Pet Intestinal Medicine Product Portfolio
- 4.10.5 Virbac Recent Developments
- 4.11 Wuhan chopperlvya
- 4.11.1 Wuhan chopperlvya Company Information
- 4.11.2 Wuhan chopperlvya Business Overview
- 4.11.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
- 4.11.5 Wuhan chopperlvya Recent Developments
- 4.12 Merck
- 4.12.1 Merck Company Information
- 4.12.2 Merck Business Overview
- 4.12.3 Merck Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Merck Pet Intestinal Medicine Product Portfolio
- 4.12.5 Merck Recent Developments
- 4.13 Zoetis
- 4.13.1 Zoetis Company Information
- 4.13.2 Zoetis Business Overview
- 4.13.3 Zoetis Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Zoetis Pet Intestinal Medicine Product Portfolio
- 4.13.5 Zoetis Recent Developments
5 Global Pet Intestinal Medicine Market Scenario by Region
- 5.1 Global Pet Intestinal Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pet Intestinal Medicine Sales by Region: 2021-2032
- 5.2.1 Global Pet Intestinal Medicine Sales by Region: 2021-2026
- 5.2.2 Global Pet Intestinal Medicine Sales by Region: 2027-2032
- 5.3 Global Pet Intestinal Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Pet Intestinal Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Pet Intestinal Medicine Revenue by Region: 2027-2032
- 5.4 North America Pet Intestinal Medicine Market Facts & Figures by Country
- 5.4.1 North America Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pet Intestinal Medicine Sales by Country (2021-2032)
- 5.4.3 North America Pet Intestinal Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pet Intestinal Medicine Market Facts & Figures by Country
- 5.5.1 Europe Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pet Intestinal Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Pet Intestinal Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pet Intestinal Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pet Intestinal Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pet Intestinal Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pet Intestinal Medicine Market Facts & Figures by Country
- 5.7.1 South America Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pet Intestinal Medicine Sales by Country (2021-2032)
- 5.7.3 South America Pet Intestinal Medicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pet Intestinal Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pet Intestinal Medicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pet Intestinal Medicine Sales by Type (2021-2032)
- 6.1.1 Global Pet Intestinal Medicine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pet Intestinal Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Pet Intestinal Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Pet Intestinal Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Pet Intestinal Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pet Intestinal Medicine Sales by Application (2021-2032)
- 7.1.1 Global Pet Intestinal Medicine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pet Intestinal Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Pet Intestinal Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Pet Intestinal Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Pet Intestinal Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pet Intestinal Medicine Value Chain Analysis
- 8.1.1 Pet Intestinal Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pet Intestinal Medicine Production Mode & Process
- 8.2 Pet Intestinal Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pet Intestinal Medicine Distributors
- 8.2.3 Pet Intestinal Medicine Customers
9 Global Pet Intestinal Medicine Analyzing Market Dynamics
- 9.1 Pet Intestinal Medicine Industry Trends
- 9.2 Pet Intestinal Medicine Industry Drivers
- 9.3 Pet Intestinal Medicine Industry Opportunities and Challenges
- 9.4 Pet Intestinal Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst